1. Home
  2. IMNM vs MCB Comparison

IMNM vs MCB Comparison

Compare IMNM & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MCB
  • Stock Information
  • Founded
  • IMNM 2006
  • MCB 1999
  • Country
  • IMNM United States
  • MCB United States
  • Employees
  • IMNM N/A
  • MCB N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MCB Major Banks
  • Sector
  • IMNM Health Care
  • MCB Finance
  • Exchange
  • IMNM Nasdaq
  • MCB Nasdaq
  • Market Cap
  • IMNM 987.1M
  • MCB 795.5M
  • IPO Year
  • IMNM 2020
  • MCB 2017
  • Fundamental
  • Price
  • IMNM $13.83
  • MCB $75.95
  • Analyst Decision
  • IMNM Strong Buy
  • MCB Buy
  • Analyst Count
  • IMNM 9
  • MCB 2
  • Target Price
  • IMNM $24.89
  • MCB $84.50
  • AVG Volume (30 Days)
  • IMNM 2.0M
  • MCB 104.9K
  • Earning Date
  • IMNM 11-12-2025
  • MCB 10-23-2025
  • Dividend Yield
  • IMNM N/A
  • MCB 0.79%
  • EPS Growth
  • IMNM N/A
  • MCB N/A
  • EPS
  • IMNM N/A
  • MCB 6.17
  • Revenue
  • IMNM $12,589,000.00
  • MCB $274,307,000.00
  • Revenue This Year
  • IMNM N/A
  • MCB $13.56
  • Revenue Next Year
  • IMNM $154.70
  • MCB $11.39
  • P/E Ratio
  • IMNM N/A
  • MCB $12.39
  • Revenue Growth
  • IMNM 16.74
  • MCB 10.33
  • 52 Week Low
  • IMNM $5.15
  • MCB $47.08
  • 52 Week High
  • IMNM $15.13
  • MCB $81.33
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 67.38
  • MCB 49.81
  • Support Level
  • IMNM $11.25
  • MCB $72.91
  • Resistance Level
  • IMNM $12.00
  • MCB $77.07
  • Average True Range (ATR)
  • IMNM 1.01
  • MCB 2.11
  • MACD
  • IMNM 0.40
  • MCB -0.37
  • Stochastic Oscillator
  • IMNM 87.06
  • MCB 38.08

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: